Retroactive Relief: How to Catch Up on Missed R&D Deductions from 2022–2024

For American innovators, the last several years have felt like a penalty on progress. Since 2022, businesses were forced to move away from the decades-old practice of deducting research and development (R&D) expenses in the year they were incurred. Instead, the Tax Cuts and Jobs Act (TCJA) mandated that these costs be amortized over five years for domestic research and fifteen years for foreign research.

This shift created a massive phantom tax for small businesses and large enterprises alike, often resulting in tax bills that exceeded a company’s actual cash flow. However, with the passage of the One Big Beautiful Bill Act (OBBBA) in mid-2025, the landscape has shifted once again. As of January 1, 2026, immediate R&D expenses are officially reborn, restoring a critical engine for American economic growth.

The End of Mandatory Amortization

The most significant change for the 2026 tax year is the retroactive repeal of mandatory Section 174 amortization for domestic expenditures. Under the OBBBA, businesses can once again elect to deduct 100% of their U.S.-based R&D costs in the year the expenses are paid or incurred. This restoration applies to a wide array of costs, including payroll for engineers, materials for prototyping, and overhead directly linked to research activities.

According to analysis from BDO on the R&D tax provisions, this change is expected to provide billions of dollars in immediate liquidity to the tech and manufacturing sectors. For many pre-revenue startups that were being taxed on their R&D spend despite having no profit, this legislative fix is quite literally a lifesaver.

Retroactive Relief: Cleaning Up the 2022-2024 Backlog

One of the most complex aspects of the new law is its retroactive nature. The OBBBA doesn’t just fix the problem for 2026, it allows businesses to catch up on the deductions they lost during the mandatory amortization years of 2022, 2023, and 2024. Taxpayers can choose to file amended returns or utilize a simplified Section 481(a) adjustment on their 2025 or 2026 returns to claim the remaining unamortized balances all at once.

This windfall of deductions can be used to offset current-year income or create a Net Operating Loss (NOL) that can be carried forward to future years. As noted by Plante Moran’s guide to Section 174 updates, navigating this retroactive period requires precise accounting to ensure that Section 174 costs are clearly distinguished from Section 162 ordinary business expenses.

Domestic vs. Foreign Research: The New Divide

While the OBBBA is overwhelmingly positive for domestic innovation, it maintains a strict barrier for international research. While U.S.-based research is now eligible for immediate 100% expensing, research performed outside of the United States must still be amortized over 15 years. This Buy American tax policy is designed to incentivize companies to repatriate their R&D centers and high-tech jobs.

For large enterprises with global R&D footprints, this creates a significant planning requirement. Companies must now meticulously track where every dollar of research is spent. If a software developer in Seattle writes the core code but a team in Bangalore performs the testing, the costs must be bifurcated to ensure the U.S. portion is expensed immediately while the foreign portion is amortized. This level of tracking is similar to the requirements for Foreign Tax Credit Optimization where jurisdictional blending is key.

Interaction with the Section 41 R&D Tax Credit

It is vital to remember that Section 174 (deductions) and Section 41 (credits) are two different mechanisms that work together. Section 174 defines what costs can be deducted, while Section 41 provides a tax credit for a subset of those costs that meet the Four-Part Test for qualified research.

With the return of immediate expense, the tax alpha of the R&D credit has increased. Under the amortization rules, the credit was often used just to pay the tax bill created by the lack of deductions. Now, the credit can once again serve its original purpose, a direct reduction of tax liability that rewards incremental innovation. According to Deloitte’s insights on R&D tax incentives, the permanence of these rules allows for much more aggressive long-term investment in experimental projects.

Software Development: No Longer a Special Case

Under the mandatory amortization rules, software development was explicitly defined as an R&D expense that had to be amortized, regardless of whether it met the classic definition of research. This was a heavy blow to the SaaS (Software as a Service) industry. The OBBBA maintains the definition that software development is a Section 174 cost but, crucially, subjects it to the new 100% immediate expensing rule for domestic work.

This means that a startup building a new platform can once again write off its entire engineering payroll in Year One. This provides a massive boost to the burn rate efficiency of tech companies, allowing them to stretch their venture capital or private equity funding much further.

Key Requirements for Section 174 Compliance in 2026:

• Direct Labor: Wages for employees performing the research.
• Contract Research: Payments to third parties for domestic research services.
• Materials and Supplies: Costs for items consumed during the development process.
• Utilities and Overhead: A reasonable allocation of rent and utilities for research facilities.

Strategic Cash Flow Planning for Large Enterprises

For big enterprises, the return of immediate expenses may impact their Effective Tax Rate (ETR) reported on financial statements. The sudden shift from capitalizing R&D to expensing it will create a large temporary difference, resulting in a significant deferred tax asset (DTA) adjustment. CFOs and tax directors should model these changes early to communicate the impact on earnings per share (EPS) to shareholders.

Furthermore, the ability to immediately expense R&D can be paired with other 100% Bonus Depreciation incentives for laboratory equipment. By stacking Section 174 expensing with Section 168(k) depreciation, a company launching a new manufacturing line can virtually eliminate its federal tax liability during the heavy R&D and setup phases.

Maximize Your Innovation Incentives

The rebirth of Section 174 immediate expense is the most significant pro-growth tax change of the decade. It removes a major hurdle for American businesses, allowing them to reinvest their cash into the next generation of products and services rather than sending it to the IRS. However, the complexity of the retroactive catch-up provisions and the strict domestic-vs-foreign bifurcation means that standard accounting is no longer enough to stay compliant.

Find an R&D Tax Strategist Today

Navigating the transition back to immediate Section 174 expensing requires a deep understanding of the OBBBA’s technical nuances and the IRS’s updated audit guidelines for research activities. Whether you are a small business owner reclaiming lost deductions from 2022 or a large enterprise restructuring your global R&D footprint, you need a qualified tax professional who specializes in innovation incentives. The Top Tax Planners Directory connects you with a curated network of elite tax strategists and R&D specialists who have successfully navigated the amortization era and are ready to help you capitalize on the new 2026 rules. Visit the Top Tax Planners Directory today to find a qualified tax professional and ensure your business is capturing every dollar of tax savings available under the new Section 174 regime.